BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 28271209)

  • 1. TGF-β
    Ehnert S; Sreekumar V; Aspera-Werz RH; Sajadian SO; Wintermeyer E; Sandmann GH; Bahrs C; Hengstler JG; Godoy P; Nussler AK
    J Mol Med (Berl); 2017 Jun; 95(6):653-663. PubMed ID: 28271209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Requirement of HDAC6 for activation of Notch1 by TGF-β1.
    Deskin B; Lasky J; Zhuang Y; Shan B
    Sci Rep; 2016 Aug; 6():31086. PubMed ID: 27499032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sub-toxic levels of cobalt ions impair chondrocyte mechanostranduction via HDAC6-dependent primary cilia shortening.
    Wu H; Wang Z; Liu S; Meng H; Liu S; Fu S
    Biochem Biophys Res Commun; 2021 Mar; 544():38-43. PubMed ID: 33516880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated expression of HDAC6 in clinical peritoneal dialysis patients and its pathogenic role on peritoneal angiogenesis.
    Shi Y; Ni J; Tao M; Ma X; Wang Y; Zang X; Hu Y; Qiu A; Zhuang S; Liu N
    Ren Fail; 2020 Nov; 42(1):890-901. PubMed ID: 32862739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of HDAC6 in ischaemia and reperfusion-induced rat retinal injury.
    Yuan H; Li H; Yu P; Fan Q; Zhang X; Huang W; Shen J; Cui Y; Zhou W
    BMC Ophthalmol; 2018 Nov; 18(1):300. PubMed ID: 30453928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HDAC6 Inhibitor Tubacin Induces Release of CD133
    Chao OS; Chang TC; Di Bella MA; Alessandro R; Anzanello F; Rappa G; Goodman OB; Lorico A
    J Cell Biochem; 2017 Dec; 118(12):4414-4424. PubMed ID: 28452069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
    Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
    PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of a Histone Deacetylase 6 Inhibitor and a Somatostatin Receptor Agonist Synergistically Reduces Hepatorenal Cystogenesis in an Animal Model of Polycystic Liver Disease.
    Lorenzo Pisarello M; Masyuk TV; Gradilone SA; Masyuk AI; Ding JF; Lee PY; LaRusso NF
    Am J Pathol; 2018 Apr; 188(4):981-994. PubMed ID: 29366679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Type I collagen promotes primary cilia growth through down-regulating HDAC6-mediated autophagy in confluent mouse embryo fibroblast 3T3-L1 cells.
    Xu Q; Liu W; Liu X; Otkur W; Hayashi T; Yamato M; Fujisaki H; Hattori S; Tashiro SI; Ikejima T
    J Biosci Bioeng; 2018 Jan; 125(1):8-14. PubMed ID: 28811097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tubacin, an HDAC6 Selective Inhibitor, Reduces the Replication of the Japanese Encephalitis Virus via the Decrease of Viral RNA Synthesis.
    Lu CY; Chang YC; Hua CH; Chuang C; Huang SH; Kung SH; Hour MJ; Lin CW
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28468311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histone deacetylase 6 inhibitor tubastatin A attenuates angiotensin II-induced hypertension by preventing cystathionine γ-lyase protein degradation.
    Chi Z; Byeon HE; Seo E; Nguyen QT; Lee W; Jeong Y; Choi J; Pandey D; Berkowitz DE; Kim JH; Lee SY
    Pharmacol Res; 2019 Aug; 146():104281. PubMed ID: 31125601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Requirement of HDAC6 for transforming growth factor-beta1-induced epithelial-mesenchymal transition.
    Shan B; Yao TP; Nguyen HT; Zhuo Y; Levy DR; Klingsberg RC; Tao H; Palmer ML; Holder KN; Lasky JA
    J Biol Chem; 2008 Jul; 283(30):21065-73. PubMed ID: 18499657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The histone deacetylase-6 inhibitor tubacin directly inhibits de novo sphingolipid biosynthesis as an off-target effect.
    Siow D; Wattenberg B
    Biochem Biophys Res Commun; 2014 Jul; 449(3):268-71. PubMed ID: 24835950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tubastatin A suppresses renal fibrosis via regulation of epigenetic histone modification and Smad3-dependent fibrotic genes.
    Choi SY; Ryu Y; Kee HJ; Cho SN; Kim GR; Cho JY; Kim HS; Kim IK; Jeong MH
    Vascul Pharmacol; 2015 Sep; 72():130-40. PubMed ID: 25921924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating the potential effects of selective histone deacetylase 6 inhibitor ACY1215 on infarct size in rats with cardiac ischemia-reperfusion injury.
    Lin CF; Hsu KC; HuangFu WC; Lin TE; Huang HL; Pan SL
    BMC Pharmacol Toxicol; 2020 Mar; 21(1):21. PubMed ID: 32178737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDAC6-dependent ciliophagy is involved in ciliary loss and cholangiocarcinoma growth in human cells and murine models.
    Peixoto E; Jin S; Thelen K; Biswas A; Richard S; Morleo M; Mansini A; Holtorf S; Carbone F; Pastore N; Ballabio A; Franco B; Gradilone SA
    Am J Physiol Gastrointest Liver Physiol; 2020 Jun; 318(6):G1022-G1033. PubMed ID: 32338033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of histone deacetylase activity suppresses epithelial-to-mesenchymal transition induced by TGF-beta1 in human renal epithelial cells.
    Yoshikawa M; Hishikawa K; Marumo T; Fujita T
    J Am Soc Nephrol; 2007 Jan; 18(1):58-65. PubMed ID: 17135397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDAC6 inhibition induces the failure of mouse early embryonic development.
    Wang H; Ling L; Ai L; Bai L
    J Cell Physiol; 2019 Jun; 234(6):8752-8759. PubMed ID: 30370558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of histone deacetylase 6 activity reduces cyst growth in polycystic kidney disease.
    Cebotaru L; Liu Q; Yanda MK; Boinot C; Outeda P; Huso DL; Watnick T; Guggino WB; Cebotaru V
    Kidney Int; 2016 Jul; 90(1):90-9. PubMed ID: 27165822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The HDAC6/8/10 inhibitor TH34 induces DNA damage-mediated cell death in human high-grade neuroblastoma cell lines.
    Kolbinger FR; Koeneke E; Ridinger J; Heimburg T; Müller M; Bayer T; Sippl W; Jung M; Gunkel N; Miller AK; Westermann F; Witt O; Oehme I
    Arch Toxicol; 2018 Aug; 92(8):2649-2664. PubMed ID: 29947893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.